Clinical trial
Study Using CP-461 to Treat Advanced Prostate Cancer
NCT00036075 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Using CP-461 to Treat Advanced Prostate Cancer
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2001
- Completion date
- December 31, 2005
- Enrollment
- 25
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer